Evidence map›Paper›PMID 32527276›Full record

Observational studyHarm reduction journal2020

Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities living with HIV.

Elizabeth C Pasipanodya, Maulika Kohli, Celia B Fisher, David J Moore, Brenda Curtis

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Harm reduction journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Mobile Health Interventions for Substance Use Disorders.Annual review of clinical psychology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Elizabeth C PasipanodyaRehabilitation Research Center, Santa Clara Valley Medical Center, San Jose, CA, 95128, USA.ORCID 0000-0001-8142-9498
Maulika KohliSan Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, 92093, USA.
Celia B FisherFordham University Center for Ethics Education, Fordham University, New York, NY, 10023, USA.
David J MooreHIV Neurobehavioral Research Program, University of California, San Diego, CA, 92103, USA. djmoore@ucsd.edu.
Brenda CurtisTechnology and Translational Research Unit, National Institute of Drug and Alcohol Abuse Intramural, Baltimore, MD, 21224, USA. brenda.curtis@nih.gov.
Fordham University · USNational Institute on Drug Abuse · USSan Diego State University · USSanta Clara Valley Medical Center · USUniversity of California San Diego · US

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello · 2001 to 2026
$50.4M
Training Program in HIV Prevention Research EthicsR25DA031608 · NIDA · FORDHAM UNIVERSITY · PI FISHER, CELIA B · 2011 to 2025
$4.9M
Reducing HIV Vulnerability in High Risks PopulationsZIADA000629 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI CURTIS, BRENDA · 2019 to 2021
$697k
Foundation for the National Institutes of Health NIDA R25 DA031608-01NIDA NIH HHS R25 DA031608NIMH NIH HHS P30 MH062512
6 · The paper itself

Abstract

backgroundMethamphetamine use poses a barrier to antiretroviral therapy (ART) adherence. Black and Hispanic men who have sex with men living with HIV (PLWH) shoulder much of the health burden resulting from the methamphetamine and HIV syndemic. Smartphones are nearly ubiquitous in the USA and may be promising vehicles for delivering interventions for ART adherence and drug use cessation. However, the acceptability of using applications to collect sensitive information and deliver feedback in this population has not been adequately explored.

objectiveThis study examined minority PLWH's appraisals of the risks of participating in smartphone-based research to promote ART adherence in the context of methamphetamine use and explored their views on appropriate steps to mitigate perceived risks of participation.

methodsThree focus groups were conducted among Black and Hispanic PLWH who use methamphetamine. Of the 13 participants, 5 had previously participated in a smartphone-based observational study of ART adherence and substance use. Discussants provided feedback on smartphone-based research, including receiving probes for HIV medication adherence, mood, and substance use as well as feedback on passive location-tracking for personalized messages. Transcribed audio-recordings were thematically coded and analyzed using the qualitative software MAXQDA.

resultsParticipants expressed confidentiality concerns related to potential unintentional disclosure of their HIV status and methamphetamine use and to possible legal consequences. They additionally expressed concerns around the invasiveness of daily assessments and the potential of methamphetamine use questions to trigger cravings. To mitigate these concerns, they suggested maintaining participant privacy by indirectly asking sensitive questions, focusing on positive behaviors (e.g., number of days sober), allowing user-initiated reporting of location to tailor messages, and ensuring adequate data protections. In addition to financial compensation, participants cited altruism (specifically, continuing a tradition of volunteerism in HIV research) as a motivator for potentially engaging in such research.

conclusionsMinority PLWH have concerns regarding the use of smartphones for ART adherence and methamphetamine sobriety intervention research. However, minority PLWH are likely to participate if studies include appropriate protections against risks to confidentiality and experimental harm and are designed to offer future benefit to themselves and other PLWH.

Indexed as

Drug MonitoringAdultAmphetamine-Related DisordersAnti-Retroviral AgentsBlack or African AmericanFocus GroupsHarm ReductionHispanic or LatinoHIV InfectionsHomosexuality, MaleHumansMaleMethamphetamineMiddle AgedMinority GroupsRiskAnti-Retroviral AgentsMethamphetamineART adherenceBioethicsHIVMethamphetaminemHealthParticipatory design

Identifiers

PMID32527276
PMCPMC7288402
OpenAlexW3035334970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.